<DOC>
	<DOC>NCT01236417</DOC>
	<brief_summary>This is a pilot study of a specifically designed exercise intervention developed for breast cancer patients with aromatase-inhibitor related joint pain.</brief_summary>
	<brief_title>Exercise Intervention in Breast Cancer Patients With Treatment-Induced Arthralgia</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Arthralgia</mesh_term>
	<criteria>Post menopausal women with a history of estrogen positive breast cancer who are receiving aromatase inhibitors for at least one month. Patients must complain of mild to moderate arthralgia. Ability to understand and sign informed consent. Patients meet criteria for low to moderate risk for moderate exercise based oon the ACSM guidelines. Inability to comply with study requirements. Metastatic breast cancer. Patients with orthopedic or neuromuscular disorders that preclude participation in exercise. Rheumatoid arthritis. History of MI, angina or congestive heart failure. Pregnant or lactating females. Patients that are high risk for moderate exercise based on ACSM risk classification. Patients who exceed minimal physical activity recommendations from the US Surgeon General's Report: Accumulation of 30 minutes or more of moderate physical activity on most days of the week. Morbidly obese with BMI â‰¥ 40</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>